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Sequential changes in renal expression of renin-angiotensin system
genes in acute unilateral ureteral obstruction. Unilateral ureteral obstruc-
tion (UUO) alters the expression of genes encoding for the renin-
angiotensin system (RAS). We tested the hypothesis that changes in RAS
genes expression occur soon after obstruction. Indeed, measurements
during the first 24 hours of UUO showed up-regulation of renin mRNA in
the obstructed kidney at 1 hour. UUO also led to increases in PRA and
renal renin content, ACE activity and Ang II concentration in the
experimental kidney. The obstructed kidney relative abundance of renin
mRNA was increased compared to basal at 1, 2, 6, and 24 hours; the
contralateral kidney renin mRNA expression was reduced. AT-R mRNA
expression was diminished at 6 and 24 hours in the obstructed kidney
compared to contralateral and sham kidneys. ACE activity was up-
regulated in the obstructed kidney and transiently down-regulated in the
contralateral kidney. These findings show for the first time that activation
of the RAS results from as little as 1 hour of UUO and that up-regulation
of renin mRNA and ACE activity lead to increase Ang II production
which down-regulates AT-R mRNA as early as 6 hours post-UUO. These
studies establish a pattern of sequential, differential regulation of the RAS
genes in acute UUO that provide an explanation for the hemodymamic
changes in this condition.
Intense vasoconstriction, the principal renal hemodynamic de-
rangement in acute complete unilateral ureteral obstruction
(UUO), results in a marked reduction in renal blood flow and
glomerular filtration rate [1, 2], and if the obstruction persists
parenchymal destruction will ensue [3, 41. Studies from this and
other laboratories have shown that acute UUO is accompanied by
complex changes in renovascular response and functional read-
justments during the first 24 hours of its course. For instance,
shortly after occlusion of the ureter, a surge in blood flow to the
affected kidney occurs which seems to be mediated by increased
production of vasodilator prostaglandins [5—7]. This response
reaches a peak at —two hours when, possibly as a direct result of
increased intrarenal prostanoid synthesis, renal renin secretion
and plasma renin activity (PRA) reach very high values [8—10]. It
appears clear that the progressive renal cortical and medullary
vasoconstriction that follows after two hours of UUO is due, at
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least partly, to enhanced intrarenal renin-angiotensin system
(RAS) activation resulting in excess production of, or increased
sensitivity to angiotensin II (Ang II). Evidence for a major role of
Ang II in the increased vascular resistance of UUO comes from
several sources [11, 121. Most important are the recent demon-
strations that inhibitors of the angiotensin I converting enzyme
(CEI) and specific, non-peptidic blockers of the Ang IT-type-I
receptor (AT1-R), such as losartan, markedly reverse the renal
hemodynamic changes of acute UUO [12, 13]. However, it is of
interest that complete recovery of the normal hemodynamic state
is not achieved even after the use of RAS blockers. This suggests
that stimulation of the RAS persists and overcomes the effect of
the pharmacological agents, and/or that other vasoconstrictors are
involved that are responsible for the residual functional changes.
The latter possibility has received substantial support mainly from
experiments in rats with acute bilateral ureteral obstruction.
Thromboxane A2, vasopressin and endothelin are among the
vasoconstrictors that have been shown to contribute to the
impaired renal hemodynamics in this model [13—15], but of these,
only thromboxane A2 has been found to play a role in the
vasoconstriction of UUO [16].
Recent experiments in our laboratory have shown that 24 hours
after UUO, the obstructed kidney exhibits marked up-regulation
in the expression of the mRNA coding for renin in both renal
cortex and medulla, and that this is accompanied by increases in
the perivascular expression of angiotensinogen (Ao) and the
endothelial expression of angiotensin I converting enzyme (ACE),
particularly of medullary medium sized vessels [12]. In chronic
UUO rat models (1 and 5 weeks duration), an increase in renal
renin mRNA steady-state concentration has also been described
which is accompanied by a down-regulation of the kallikrein-kinin
system [17, 18]. It is of interest that in this chronic model a
decrease in renal Ao mRNA was found at both 1 and 5 weeks. The
studies alluded to [12, 17] indicate that in UUO the RAS is
differentially regulated, not only in various kinds of renal struc-
tures, but also as a function of duration of the obstruction.
Nevertheless, the timing of the earliest changes in RAS regulation
in UUO is unknown and the relationship among the components
of the RAS in these periods unexplored. In view of the beneficial
response to CEI and to Ang II receptor antagonists at 1 day, and
1 and 5 weeks after UUO, we tested the hypothesis that early
changes in the regulation of the genes coding for the RAS is a
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fundamental determinant of the functional manifestations of
UUO. Knowledge of the earliest changes in the RAS response to
UUO may be critical in understanding the mechanisms by which
gene expression is regulated in this model.
Methods
Surgical procedures
Experiments were performed in male Wistar rats weighing 150
to 200 g (Charles River Laboratories, Raleigh, NC, USA). The
animals were housed individually in a room providing 12-hour
light and dark cycles and were maintained on standard rat chow
(Purina 5010, Purina Mills, Richmond, IN, USA) with free access
to food and water at all times prior to the experiment. Rats were
subjected to UUO or sham operation. General anesthesia was
induced by intraperitoneal injection of ketamine (100 mg/kg body
wt) and xylazine (10 mg/kg body wt). To create a state of UUO,
the left distal ureter was identified through a small suprapubic
incision, dissected from its retroperitoneal site, and completely
occluded by a 4 to 0 silk square knot. Sham operation consisted of
a similar suprapubic incision and visualization of the left distal
ureter without further manipulation. The abdominal incision was
closed and animals were allowed to recover from the anesthesia
prior to returning to individual cages. The experimental proce-
dure used in animals subjected to renal hemodynamic studies is
describe below under renal clearance studies.
Experimental groups
Experiments were performed after acute UUO at 1 (N = 15),
2 (N = 26), 6 (N = 15), 12 (N = 15), and 24 hours (N = 22). At
0 hour (basal values; N = 12) the ureter was occluded (clamped)
and immediately released. All other rats underwent closure and
re-opening of their abdominal surgical incisions. At 1 hour, rats
had not yet recovered from the anesthesia when samples were
obtained. All others were fully awake before undergoing re-
anesthesia and sample collection. Animals studied at 2, 6, 12, and
24 hour were kept in individual metabolic cages with free access to
food and water until sacrificed. At each time period, two to three
shams were studied. The contralateral (untouched) kidney is
always referred to as the control kidney while UUO is used to
refer to the obstructed kidney.
Renal clearance studies
Renal hemodynamics were measured in four awake rats after
two hours of UUO or sham operation. For this purpose, rats were
anesthetized as described above, the right external jugular vein,
right carotid artery, left ureter, and urinary bladder were cannu-
lated, the surgical incisions were closed, the catheters were
externalized, and the animals were placed in plexiglass holders
and allowed to awaken. To induce a state of UUO, the left
ureteral catheter lumen was occluded with a metal pin at 0 hour.
3H-inulin (2 jCi) and '4C-para-aminohippurate (1 xCi) were
given as an intravenous bolus in 0.2 ml normal saline followed by
a continuous intravenous infusion delivering 0.1 xCi of 3H-inulin
and 0.05 tCi of '4C-para-aminohippurate per minute. Sham
animals did not have the left ureteral cannula occluded. After two
hours, the metal pin was removed from the left ureteral catheter,
and timed urine (from left ureter cannula and urinary bladder
separately) and plasma samples were collected and handled as
previously described [121. The animals arterial blood pressure was
monitored throughout the experimental procedure.
Tissue harvesting and preparation
For studies of mRNA expression and renal renin content
(RRC) determination, groups of eight rats at each time period
after UUO or sham operation were used. One-half of the
obstructed (or sham) and one-half of the control kidney were
rapidly frozen in liquid nitrogen for RNA isolation and Northern
blot analysis and the other half was homogenized in a tissue
homogenizer (Tekmar, Cincinnati, OH, USA) in 0.2 M phosphate
buffer pH 6.5, containing 1.5% ammonium EDTA for tissue RRC
measurement.
For measurement of PRA, a separate group of UUO and sham
rats were decapitated (N = 7 for each period) and trunk blood
collected into a pre-chilled microcentrifuge tube containing
EDTA (5 mM). Plasma samples were stored at —20°C until
analysis.
Separate groups of seven rats each were studied for measure-
ment of whole kidney ACE activity and Ang II concentration.
After the rats were decapitated, the kidneys were harvested,
decapsulated, blotted dry, bisected and each half weighed. One-
half of each kidney was homogenized in cold 100% methanol
(containing no inhibitors, 10% wt/vol) and the other half was
frozen in liquid nitrogen. All these steps were completed within 90
seconds of decapitation in all rats studied; if a delay occurred, the
respective tissues were discarded. Measurements of ACE activity
and Ang II concentration were made in shams only at 6 and 24
hours, which were the points of major changes in the experimental
groups and were not measured at 1 hour in any group.
RNA extraction and Northern hybridization analysis
Total RNA was extracted by the guanidine thiocyanate method,
as described previously [191. A total of 20 ig RNA was run on
agarose gels using 2.2 M formaldehyde. RNA was transferred by
capillary blotting using standard procedures and Immobilon-N
membranes (charge-modified PVDF transfer membranes, Milli-
pore Corporation, Bedford, MA, USA). Blots were washed in 6 X
SSC for five minutes, then baked under vacuum for 1 hour at
80°C.
Renin and A T7-R cDNA
Renin eDNA was obtained as a courtesy of Dr. K. Lynch,
University of Virginia. It was originally isolated from a rat kidney
Agt 10 library, subcloned into the EcoRI site of the plasmid
Bluescript, excised with BamHI and HindIII and subcloned into
the same sites in the plasmid pGEM4 (Promega Corporation,
Madison, WI, USA). The insert is —1425 bp; transcription from
the T7 promoter yielded antisense cRNA. The AT1-R cDNA was
a gift of Drs. T.J. Murphy and R.W. Alexander (Emory University
School of Medicine, Atlanta, GA, USA); it was originally cloned
in the pCDM8 expression vector by Murphy et al [20] and was
subcloned into the pGEM4 vector.
Preparation of riboprohes
Riboprobes were transcribed using 0.5 to 1 pg linearized
plasmid and labeled using 32P-UTP (1200 Ci/mmol, Amershan,
Arlington Heights, IL, USA). A full-length antisense transcript
was used for hybridization. Purified riboprobes were stored in
70% ethanol at —20°C.
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Prehybridization and hybridization
Blots were prehybridized for six hours at 60°C with hybridiza-
tion buffer [50% formamide, 5 X SSC (1 X SSC: 0.15 M NaC1,
0.015 M sodium citrate, pH 7], 8 x Denhardt's solution, 1 ifiM
EDTA, 0.1% sodium pyrophosphate, and 0.5% SDS, 200 tg/ml
denatured salmon sperm DNA]. A mixture of 0.5 to 1.0 x i0
CPM probe in 0.2 ml hybridization buffer was heated to 85°C for
five minutes, added to 4 ml hybridization buffer and 1 ml 50%
dextran sulfate and thoroughly mixed. Hybridization was carried
out overnight (16 to 18 hr) at 60°C. Membranes were washed for
30 minutes, first in 2 X SSC + 0.2% SDS at 65°C and finally in 0.2
>< SSC + 0.2% SDS at 70°C. Dry blots were exposed overnight
with intensifying screen on Kodak film xRP-5.
Membrane reprobing
For reprobing with glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) cRNA, membranes that had been previously hybrid-
ized were washed in 0.1 N NaOH for 30 minutes at room
temperature. A Geiger counter check was carried out until there
was no detectable radioactivity. After the membranes were neu-
tralized by immersion in 0.02 M Tris-HC1 (pH 8) + 0.1 X SSC +
0.5% SDS for 45 to 60 minutes, they were ready to be reprobed.
Prehybridization and hybridization for GAPDH mRNA were
performed as described above.
Densitometiy analysis and mRNA quantification
The autoradiographs were scanned with a MD Image Quant
228 densitometer (Molecular Dynamics, Sunnyvale, CA, USA).
Results are expressed as relative densities which were determined
by dividing the signal density of each RNA sample hybridized to
the renin and AT-R riboprobes to that hybridized to the
GAPDH probe. In addition, we used ultraviolet light to detect the
18S and 28S ribosomal RNAs in gels stained with ethidium
bromide to ascertain equal RNA loading. We have previously
shown that UUO does not alter GAPDH mRNA expression [12,
21].
Analytical procedures
RRC was measured as previously reported [221. Briefly, the
amount of angiotensin I (Ang I) generated during one hour of
incubation at 37°C in the presence of CE!, excess rat substrate,
and protease inhibitors was measured by radioimmunoassay
(Rianen Assay System, Du Pont Company, Billerica, MA, USA).
The values are expressed as nanograms of Ang I/mg of tissue
protein/hour.
For PRA determination, the plasma samples were incubated as
above but without added substrate. The values are expressed as
nanograms of Ang I/mi/hour.
ACE activity in kidney homogenate supernatants was deter-
mined by a fluorimetric measurement of the enzymatic cleavage
of hippurate from hippuryl-histidyl-leucine as previously de-
scribed [17, 23]. The activity of the enzyme is expressed as
nmol/min/g of kidney weight. Intrassay variability was < 3%.
For Ang II concentration measurements, kidney tissue homo-
genates were centrifuged at 3000 g at 4°C for 10 minutes, and the
supernatants removed and stored at —70°C. The details of the
elution, and radioimmunoassay of Ang II have been previously
described [24]. The concentration of the peptide is expressed as
fmol/gram of kidney weight.
Table 1. Renal hemodynamics in conscious rats immediately after
release of left UUO or sham of two hours duration
Sham (N = 4) UUO (N = 4)
Left Right Left Right
MAP mm Hg 98±2 100±2
GFR mI/mm/kg 8.3 0.2 8.1 0.2 8.6 0.2 9.0 0.2
ERPF mI/mm/kg 17.1 0.3 18.3 0.4 24.0 0.2° 20.1 0.3
FF% 49±2 44±2 35±1.1° 45±1.1
Data are mean SE.
Abbreviations are: GFR, glomerular filtration rate; ERPF, effective
renal plasma flow; FF, filtration fraction; MAP, mean arterial pressure.
P < 0.001 compared to UUO right and Sham kidneys
Tissue protein content was determined by a dye-binding assay
(Bio-Rad, Chemical Division, Richmond, CA, USA) as described
by Bradford [25].
Statistical methods
Data are expressed as mean SEM. One way analysis of
variance (ANOVA) was used for comparisons between groups.
When each animal was used as its own control (left vs. right
kidney) significance was obtained by unpaired t-test. A value of p
< 0.05 was accepted as statistically significant.
Results
Renal hemodynamics after two hours of UUO or
sham intervention
Table 1 shows renal clearance studies after two hours of UUO
or Sham operation. Mean arterial pressure did not differ between
groups. In the obstructed kidneys, the ERPF was significantly
higher compared to contralateral and sham kidneys but the GFR
was similar among all groups. Thus, filtration fraction in the UUO
kidney diminished significantly compared to the control and sham
kidneys.
Plasma renin activity, renal renin content and renal ACE activity
in UUO
PRA (Fig. 1) rose almost 12-fold from control by 1 hour,
remained at least ninefold higher than control through 12 hours,
and it returned toward basal values at 24 hours. In sham rats, PRA
did not change at any time after surgery. RRC (Fig. 2) was equal
on both sides at 0 hour, but was higher in the obstructed as
compared to the control kidney at 1, 2, 6, 12 and 24 hours.
Conversely, the control kidney RRC did not change during the
first 12 hours but its RRC was significantly lower than basal and
UUO values at 24 hours. PRA grossly paralleled the RRC of the
UUO kidneys. Basal ACE activity did not differ in control and
UUO kidneys, but 2 hour measurements were higher in UUO
than in control kidneys (Fig. 3). By 6 hours, ACE activity rose
markedly in the UUO kidney and remained elevated throughout
the 24 hour period. In contrast, ACE activity in the control kidney
was lower at 2 and 6 hours, returned to baseline values at 12
hours, and was higher than basal values at 24 hours after UUO.
RRC and ACE activity did not differ between left and control
kidneys in shams at any time (data not shown). Therefore, while
UUO kidney RRC rose beginning 1 hour after UUO, ACE
activity did not rise until 6 hours post-UUO. At six hours, both
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Fig. 1. Mean (±sE) changes in PRA after UUO (U,' N = 7 each period) or
sham ( N = 7 each period). Zero hours represent baseline values as
described in experimental groups under materials and methods. *P <
0.001 for the comparison with the baseline group. At 24 hours, PRA values
were not different from baseline in UUO rats. Sham values at different
times after surgery did not change significantly from basal values.
Time, hours
Fig. 2. Mean (±sE) changes in RRC (N = 8 each period) after (JUO (LI).
The values of the control kidney () did not differ from its basal values. *P
< 0.03 for the comparison with the baseline and control values; ** P <
0.04 compared to basal values.
0 2 6 12 24
Time, hours
Fig. 3. Mean (±sE) changes in kidney ACE activity after UUO (N = 7each
period). Symbols are: (LI) UUO; () control. *P < 0.02 for the compar-
ison with the basal values; +P < 0.01 compared to control group; **P <







Fig. 4. Mean (±sE) changes in renalAng 11 concentration after UUO (N =
7each period). Symbols are: (LI) UUO; () control. *1' < 0.04 compared
to basal values; ** <0.01 for the comparison with the control group and
basal values.
ACE activity and RRC remained elevated in the UUO compared
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Kidney angiotensin II concentration
Basal concentration of Ang II did not differ between the control
and UUO kidneys; these did not differ from sham animals (Fig. 4).
After 2 hours of UUO, both UUO and control kidney values were
significantly higher when compared to basal and sham values. No
difference could be found between the UUO and the control
kidneys at this time. By 24 hours, the concentration of Ang II in
the two kidneys was markedly elevated compared to basal values,
and was higher in the control than in the obstructed kidney.
A
hours 1 2 6
I II II
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hours 1 2 6
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Fig. 5. Sequential changes in kidney renin mRNA after UUO. Representa-
tive Northern blots of the obstructed (A) and the control kidneys RNA
(It), from rats sacrificed after 1, 2 and 6-hr of UUO. A total of 20 sg whole
kidney RNA was loaded in each lane; each lane represents a different rat.
Equality of loading after electrophoresis was checked by ethidium bro-
mide staining. C. Bar graph shows densitometric analysis of all Northern
blots probed for renin mRNA. Symbols are: (El) UUO; () control. Data
are mean SEM < 0.02 versus basal values; < 0.03 versus control
group and basal values.
Renal renin mRNA and ATIRmRNA
The time course changes in kidney renin mRNA expression are
shown in Figure 5. UUO renin mRNA started to rise at 1 hour,
and by 2 hours attained values —threefold compared to control
and basal values (Fig. 5C). Values remained elevated in the UUO
compared to the control kidney throughout the 24 hour period. It
may be seen that control kidney renin mRNA was significantly
diminished beginning at 1 hour after UUO.
The pattern of changes in AT1-R mRNA differed completely








Fig. 6. Sequential changes in mean (±sE) kidney AT1-R mRNA levels after
UUO. Graph represents densitometric analysis of all Northern blots
probed for AT1-R mRNA. Symbols are: (U) UUO; () control. P <
0.001 versus basal values.
mRNA were detected in the obstructed kidney as early as 6 hours
and levels were markedly lower at 24 hours (Fig. 6). As may be
seen, in contralateral and sham kidneys (latter not shown) the
relative abundance of AT1-R mRNA did not change throughout
the various study periods. Measurements of AT1-R mRNA at 12
hours were not performed.
Discussion
The present study demonstrates that in acute UUO marked
changes in the RAS take place as early as one hour after
obstruction, which may further explain the hemodynamic alter-
ations in this condition. It is clear that the relative abundance of
renin mRNA in the obstructed kidney coincided with elevations in
RRC, ACE activity and renal Ang II concentration. In addition,
the levels of AT1 mRNA in the obstructed kidney were down-
regulated starting at 6 hours and persisting at 24 hours post-
obstruction. By 24 hours, the contralateral kidney exhibited
reductions in ACE activity and renin mRNA.
The increased relative abundance of renin mRNA in the UUO
kidneys at one hour which was associated with a rise in renal renin
content (RRC) is a novel finding. While the relationship between
PRA and renin gene expression was not quantitatively equal, the
sharp early increase in PRA must be due to increase renal renin
secretion, since during the first two hours renal plasma flow rose
(secretion is dependent on RRC and RPF). Furthermore, the
persistent increase in PRA at 6 and 12 hours must have also
reflected increased synthesis of renin and secretion since RPF
falls at these times [3].
The present experiments demonstrate that the marked vasodi-
lation of the obstructed kidney observed two hours after the onset
of UUO occurs despite increased RRC and Ang II concentration.
Previous studies in anesthetized dogs, rabbits and rats have shown
that the profound vasodilation of the obstructed kidney is the
result of the release of prostaglandins [5—7]. Our previous [12, 21]
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and present studies provide direct evidence that the most likely
stimulus for prostaglandin secretion, or for the production of
other vasodilators such as bradykinin and nitric oxide, is early
activation of RAS, since Ang II can induce prostanoid synthesis
[26] as well as induce nitric oxide release [27]. Moreover, studies
by Chevalier, Thornhill and Gomez [28] indicate that nitric oxide
activity is up-regulated in acute UUO in the rat, while acute
bilateral ureteral obstruction have been associated with reduction
in nitric oxide activity [29].
The concomitant elevation of renal ACE activity and intense
kidney vasoconstriction at 6 to 12 hours post-UUO is strong
evidence that Ang I generated from the effect of high RRC on Ao
was being converted to Ang II, which increases thromboxane A2
synthesis as shown by Yanagisawa et al [26], thus leading to the
renal vasoconstriction of UUO. Furthermore, since it has been
shown that renal Ang II content rises in response to acute UUO
in pigs [30] and that the renal hemodynamics are improved by
treatment with losartan [12], we feel that this is conclusive
evidence that the renal vasoconstriction is Ang Il-mediated.
Moreover, as shown here for the first time for the kidney in early
UUO, marked down-regulation of the AT1-R mRNA suggests a
negative feedback between the receptor gene and Ang II as has
been previously suggested [21, 31, 32]. The fact that renin mRNA
also fell toward its basal values between 2 and 24 hours after
obstruction, a time of the most profound down-regulation of the
AT1-R mRNA, is also indirect evidence for a local effect of Ang
II, which has been shown to have a negative feedback effect on
renin mRNA [33, 34].
The failure to detect a change in control AT1 mRNA at a time
when PRA and renal Ang II were elevated (2 hr) is presently
difficult to explain. Since we did not measure Ang II at all
intervals, it might be argued that a change in concentration of the
octopeptide was transient and that the levels were normalized by
6 hours. This seems unlikely since the AT1 mRNA levels were
basically unchanged in the contralateral kidney at all periods. It is
of interest, however, that despite elevations in PRA and intrarenal
Ang II concentration, the control kidney does not ethibit vaso-
constriction in this model, nor does it respond (at least at 24 hr)
to losartan or converting enzyme inhibitors with elevations in
renal blood flow [12, 21]. While a role of a vasodilator substance
in modifying the response of the contralateral side to Ang II
cannot be deduced from our experiments, this is indeed the case
in two kidney-one clip experimental Goldblatt hypertension,
another model in which plasma renin activity and Ang II concen-
tration are elevated [35]. In this model, L-NAME an inhibitor of
nitric oxide synthesis reduced renal blood flow to the unclipped
kidney by 61%, while losartan normalized blood flow to the
clipped kidney, but did not modify it in the non-clipped kidney
[35]. Therefore, as may be the case in UUO, Ang II effects
predominate in the experimental kidney, but are modified by a
vasodilator in the contralateral side.
It is clear from the present experiments that UUO results in a
series of complex hemodynamie alterations and changes in the
transcriptional regulation of the genes that code for members of
the RAS. The molecular mechanisms of the changes in transcrip-
tion cannot be discerned from the present experiments. Yet, our
studies present convincing evidence that some effect of UUO-
possibly stretch or pressure-differentially regulates the genes
coding for renin and the AT1-R over time [36]. Furthermore, the
present study shows for the first time that the RAS genes are
induced as early as one hour post-UUO, and that once the RAS
cascade is turned on, Ang II can serve as feedback for the
regulation of renin, ACE and its own receptor mRNA in the
obstructed kidney.
In summary, UUO leads to an early differential regulation of
the RAS genes, which at least partly explains the changes in renal
hemodynamie alterations seen during the first 24 hours of obstruc-
tion.
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